Journalartikel

Letter to the Editors: Concerning "Divergent clinical outcomes of alpha-glucosidase enzyme replacement therapy in two siblings with infantile-onset Pompe disease treated in the symptomatic or pre-symptomatic state" by Takashi et al. and Letter to the Editors by Ortolano et al.


AutorenlisteSchaenzer, Anne; Giese, Kerstin; Viergutz, Lara; Hahn, Andreas

Jahr der Veröffentlichung2017

Seiten33-34

ZeitschriftMolecular Genetics and Metabolism Reports

Bandnummer12

ISSN2214-4269

Open Access StatusGold

DOI Linkhttps://doi.org/10.1016/j.ymgmr.2017.05.005

VerlagElsevier



Zitierstile

Harvard-ZitierstilSchaenzer, A., Giese, K., Viergutz, L. and Hahn, A. (2017) Letter to the Editors: Concerning "Divergent clinical outcomes of alpha-glucosidase enzyme replacement therapy in two siblings with infantile-onset Pompe disease treated in the symptomatic or pre-symptomatic state" by Takashi et al. and Letter to the Editors by Ortolano et al., Molecular Genetics and Metabolism Reports, 12, pp. 33-34. https://doi.org/10.1016/j.ymgmr.2017.05.005

APA-ZitierstilSchaenzer, A., Giese, K., Viergutz, L., & Hahn, A. (2017). Letter to the Editors: Concerning "Divergent clinical outcomes of alpha-glucosidase enzyme replacement therapy in two siblings with infantile-onset Pompe disease treated in the symptomatic or pre-symptomatic state" by Takashi et al. and Letter to the Editors by Ortolano et al.. Molecular Genetics and Metabolism Reports. 12, 33-34. https://doi.org/10.1016/j.ymgmr.2017.05.005



Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-10-06 um 10:48